NewsFriday, 20. July 2012
The eBase Controller – the new Control Unit for the eFlowrapid with many Extras
Compact, light, quiet and fast: for many years, the eFlowrapid has represented an improvement in quality of life for cystic fibrosis cystic fibrosis
Genetic disorder that affects most critically the lungs, leading to thick, viscous secretions. patients through effective inhalation. The new eFlowrapid with eBase Controller was presented to the public for the first time at the ECFS Conference from 6-9 June 2012 in Dublin, which recorded a record attendance of 2,400 participants from 58 countries.
The new eFlowrapid control unit generated a lot of interest, not only because of its modern design, but also because of its large display: the display provides the user a lot of additional information during inhalation and provides feedback on important points. For example, the battery charge level is displayed and feedback on the fill level of medication is given. The user can even use the new controller to find out whether the cable connector is working properly.
The new control unit will replace the older, turquoise-coloured controller with immediate effect, and is compatible with both the eFlowrapid nebuliser handset and drug-specific nebuliser handsets (e.g., Altera for Cayston).